Stockscreener 앱 받기
6.07
1.17%
0.07
시간 외 거래:
5.97
-0.10
-1.65%
전일 마감가:
$6.00
열려 있는:
$5.956
하루 거래량:
6,019
Relative Volume:
0.02
시가총액:
$68.46M
수익:
$800.00K
순이익/손실:
$-45.07M
주가수익비율:
-1.1544
EPS:
-5.2583
순현금흐름:
$-52.08M
1주 성능:
+2.88%
1개월 성능:
+7.43%
6개월 성능:
-10.34%
1년 성능:
+0.00%
1일 변동 폭
$5.87
$6.07
1주일 범위
$5.56
$6.07
52주 변동 폭
$3.94
$17.96
Imagenebio Inc Stock (IMA) Company Profile
명칭
Imagenebio Inc
전화
857-343-8292
주소
12526 HIGH BLUFF DRIVE, SAN DIEGO
Compare IMA vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMA
Imagenebio Inc
|
6.07 | 67.67M | 800.00K | -45.07M | -52.08M | -5.2583 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Imagenebio Inc Stock (IMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 재개 | Wedbush | Underperform |
| 2025-10-24 | 개시 | Leerink Partners | Outperform |
Imagenebio Inc 주식(IMA)의 최신 뉴스
ImageneBio Appoints Matt Robbins as General Counsel - The Manila Times
Enterprise value to revenue forward of ImageneBio, Inc. – NASDAQ:IMA - TradingView
Enterprise value to EBIT forward of ImageneBio, Inc. – BOATS:IMA - TradingView
IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally? - Stocktwits
ImageneBio (IMA) prospectus supplement registers 2.5M shares for resale - Stock Titan
Price to earnings forward of ImageneBio, Inc. – NASDAQ:IMA - TradingView
Price to book forward of ImageneBio, Inc. – NASDAQ:IMA - TradingView
Price to sales forward of ImageneBio, Inc. – NASDAQ:IMA - TradingView
Price to sales forward of ImageneBio, Inc. – BOATS:IMA - TradingView
Price to earnings forward of ImageneBio, Inc. – BOATS:IMA - TradingView
Enterprise value to EBITDA forward of ImageneBio, Inc. – BOATS:IMA - TradingView
ImageneBio Announces Upcoming Transition in Financial Leadership - TipRanks
Imagenebio (NASDAQ: IMA) finance chief Robert Lally to step down - Stock Titan
Imagenebio, Inc. Announces Resignation of Robert Lally as Senior Vice President of Finance and Operations, Effective July 22, 2026 - marketscreener.com
ImageneBio, Inc. Actuals & Estimates (NASDAQ:IMA) - TradingView
IMA Forecast — Price Target — Prediction for 2027 - TradingView
ImageneBio Ord Shs (IMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ImageneBio Ord Shs (IMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ImageneBio Shareholders Back Directors and Governance Proposals - The Globe and Mail
ImageneBio stockholders approve equity plan amendment and elect directors By Investing.com - Investing.com India
ImageneBio Ord Shs (IMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ImageneBio stockholders approve equity plan amendment and elect directors - Investing.com UK
ImageneBio Ord Shs (IMA) Institutional Confidence - TradingKey
ImageneBio Ord Shs (IMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ImageneBio Inc. (IMA) Slips 1.58% as Stock Nears Critical Support LevelFloat Adjusted Cap - newsline.com
IMA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Ramps Up R&DGuidance Downgrade Alert - dars.gov.et
IMA Q1 2026 Earnings: Wider-than-expected loss as EPS misses estimatesOne-Time Loss Impact - newsline.com
IMA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineNew Analyst Coverage - newsline.com
IMA Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing R&D InvestmentsDividend Earnings Report - newsline.com
ImageneBio Inc. (IMA) Q1 2026 Earnings: EPS Misses Estimates Amid Development Stage StatusMargin Expansion Trends - dars.gov.et
Ikena Oncology Inc stock (US4517401090): trading in United States halted as ImageneBio merger progre - AD HOC NEWS
Imagenebio Inc. Live Share Prices and Trades. IMA.US Live Streaming Share Prices. - London South East
IMA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Reports Wider LossRevenue Miss Report - dars.gov.et
ImageneBio (IMA) Holds Steady at $5.92 as Traders Eye Support and ResistanceMFI Oversold - dars.gov.et
ImageneBio CEO to present at 2026 Jefferies Global Healthcare Conference in New York - Pluang
ImageneBio CEO to speak at New York Jefferies healthcare conference June 4 - Stock Titan
IMA stock surges 24%, breaks 50-DMA for first time since February – what's driving the rally? - MSN
IMAImageneBio Inc Stock Price and Quote - Finviz
ImageneBio (IMA) Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineCommunity Breakout Alerts - Newser
ImageneBio (IMA) Q1 2026 Results Fall Short — EPS $-0.95, Revenue $N/AExpert Stock Picks - Newser
ImageneBio (IMA) Q1 2026 Stumbles — EPS $-0.95 Misses TargetReturn On Assets - Newser
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade - MSN
ImageneBio $30 million private placement ignites stock - MSN
Imagenebio Inc (IMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Imagenebio Inc 주식 (IMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bonita David P | Director |
Jul 25 '25 |
Buy |
29.90 |
83,611 |
2,499,969 |
287,885 |
| Stampacchia Otello | Director |
Jul 25 '25 |
Buy |
29.90 |
267,556 |
7,999,924 |
454,982 |
1.17%
2.48%
자본화:
|
볼륨(24시간):